Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melina Verso

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
Internal and Emergency Medicine|April 5, 2015
Pros and cons of new oral anticoagulants in the treatment of venous thromboembolism in patients with cancerMelina Verso, Giancarlo Agnelli, Paolo Prandoni
Internal and Emergency Medicine|May 25, 2023
Ambulatory cancer patients: who should definitely receive antithrombotic prophylaxis and who should never receiveMelina Verso, Andres Muñoz, Jean M Connors
Haematologica|June 8, 2019
Updated meta-analysis on prevention of venous thromboembolism in ambulatory cancer patientsCecilia Becattini, Melina Verso, Andres Muňoz, et al.
Journal of Thrombosis and Thrombolysis|September 16, 2017
Reversal of dabigatran-associated bleeding using idarucizumab: review of the current evidenceMichela Giustozzi, Melina Verso, Giancarlo Agnelli, et al.
Trends in Cardiovascular Medicine|February 12, 2022
Unmet clinical needs in the prevention and treatment of cancer-associated venous thromboembolismMichela Giustozzi, Laura Franco, Giancarlo Agnelli, et al.
Haematologica|April 17, 2025
Response to Comment on: "Targeted anti-cancer agents and risk of venous thromboembolism"Melina Verso, Florian Moik, Mara Graziani, et al.
Haematologica|December 2, 2024
Targeted anti-cancer agents and risk of venous thromboembolismMelina Verso, Florian Moik, Mara Graziani, et al.
Thrombosis Research|April 29, 2018
Treatment of venous thromboembolism in patients with cancer: What news from clinical trials?Melina Verso, Laura Franco, Michela Giustozzi, et al.
Internal and Emergency Medicine|June 11, 2011
Prevalence of risk factors for venous thromboembolism in the Italian population: results of a cross-sectional study from the Master RegistryWalter Ageno, Giancarlo Agnelli, Davide Imberti, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|June 12, 2008
Seasonal variation in the occurrence of venous thromboembolism: data from the MASTER RegistryRoberto Manfredini, Davide Imberti, Massimo Gallerani, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Internal and Emergency Medicine|April 5, 2015
Pros and cons of new oral anticoagulants in the treatment of venous thromboembolism in patients with cancerMelina Verso, Giancarlo Agnelli, Paolo Prandoni
Internal and Emergency Medicine|May 25, 2023
Ambulatory cancer patients: who should definitely receive antithrombotic prophylaxis and who should never receiveMelina Verso, Andres Muñoz, Jean M Connors
Haematologica|June 8, 2019
Updated meta-analysis on prevention of venous thromboembolism in ambulatory cancer patientsCecilia Becattini, Melina Verso, Andres Muňoz, et al.
Journal of Thrombosis and Thrombolysis|September 16, 2017
Reversal of dabigatran-associated bleeding using idarucizumab: review of the current evidenceMichela Giustozzi, Melina Verso, Giancarlo Agnelli, et al.
Trends in Cardiovascular Medicine|February 12, 2022
Unmet clinical needs in the prevention and treatment of cancer-associated venous thromboembolismMichela Giustozzi, Laura Franco, Giancarlo Agnelli, et al.
Haematologica|April 17, 2025
Response to Comment on: "Targeted anti-cancer agents and risk of venous thromboembolism"Melina Verso, Florian Moik, Mara Graziani, et al.
Haematologica|December 2, 2024
Targeted anti-cancer agents and risk of venous thromboembolismMelina Verso, Florian Moik, Mara Graziani, et al.
Thrombosis Research|April 29, 2018
Treatment of venous thromboembolism in patients with cancer: What news from clinical trials?Melina Verso, Laura Franco, Michela Giustozzi, et al.
Internal and Emergency Medicine|June 11, 2011
Prevalence of risk factors for venous thromboembolism in the Italian population: results of a cross-sectional study from the Master RegistryWalter Ageno, Giancarlo Agnelli, Davide Imberti, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|June 12, 2008
Seasonal variation in the occurrence of venous thromboembolism: data from the MASTER RegistryRoberto Manfredini, Davide Imberti, Massimo Gallerani, et al.
Pageof 5